Hormonal
Pre-pregnancy lifestyle interventions (dietary restriction or exercise) initiated at least 9 weeks prior to conception reduce the risk of metabolic-associated fatty liver disease (MAFLD) in offspring of obese mothers, whereas interventions initiated only 1 week prior do not.
If you have obesity and plan to conceive, starting weight management 9+ weeks before trying to get pregnant is critical for your future child's liver health. Standard lifestyle changes may take too long, so discuss pre-pregnancy pharmacotherapy (like GLP-1 agonists) with your doctor to ensure you reach a healthy weight before conception.
dietary intervention only 1 week prior to conception did not alleviate the risks associated with maternal obesity for the offspring... However, similar to the study in Japanese macaques, this was avoided in the offspring of mothers with dietary intervention 9 weeks prior to conception, suggesting that early maternal dietary intervention is effective in reducing the risk of MAFLD in the offspring of mothers with obesity [52].
Why this rating
Based on preclinical animal models (mice, macaques, baboons) and human cohort associations, but lacks direct human interventional trials for offspring liver outcomes.
Source
Maternal Weight Management to Prevent the Developmental Programming of MAFLD in Offspring of Obese Mothers
Amanda R. Purcell et al. · Nutrients · 2023
DOI 10.3390/nu15092155
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →